feed,title,long_url,short_url
Benzinga,"Cingulate Kickstarts Pivotal Trial For ADHD Candidate, Data Expected In First Half 2023",https://benzinga.com/general/biotech/23/01/30269779/cingulate-kickstarts-pivotal-trial-for-adhd-candidate-data-expected-in-first-half-2023,https://da.gd/0TZ5N
Benzinga,Key Tesla Rival Rivian Misses 2022 Production Target As Supply Chain Challenges Hurt,https://benzinga.com/news/23/01/30269375/key-tesla-rival-rivian-misses-2022-production-target-as-supply-chain-challenges-hurt,https://da.gd/XLyz
